An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
about
Current pharmacotherapeutic strategies for overactive bladder.Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin.Oxybutynin extended release for the management of overactive bladder: a clinical review.Inappropriate medication prescribing in residential care/assisted living facilities.Complications of sacral anterior root stimulator implantation in a cervical spinal cord injury patient: increased spasms requiring intrathecal baclofen therapy followed by delayed fracture of lumbar spine leading to intractable spasms compelling disStudies on bi-layer osmotic pump tablets of water-insoluble allopurinol with large dose: in vitro and in vivo.
P2860
An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
An extended-release formulatio ...... of overactive urinary bladder.
@ast
An extended-release formulatio ...... of overactive urinary bladder.
@en
type
label
An extended-release formulatio ...... of overactive urinary bladder.
@ast
An extended-release formulatio ...... of overactive urinary bladder.
@en
prefLabel
An extended-release formulatio ...... of overactive urinary bladder.
@ast
An extended-release formulatio ...... of overactive urinary bladder.
@en
P1476
An extended-release formulatio ...... of overactive urinary bladder.
@en
P2093
Goldenberg MM
P304
P356
10.1016/S0149-2918(00)88316-2
P577
1999-04-01T00:00:00Z